-
-
-
-
-
-
-
Auris Medical Announces Publication of New Data Highlighting the Role of Betahistine in Promoting the Restoration of Forgotten Memories in Mice and Healthy Volunteers
-
-
-
-
-
-
-
Auris Medical Holding (EARS) Says TACTT3 Clinical Trial with Keyzilen Did Not Meet Primary Endpoint
-
-
-
-
-
-
-
Auris Medical Expands Clinical Development Pipeline with Intranasal Betahistine for the Treatment of Meniere's Disease and Vestibular Vertigo
-
-
-
-
-
-
-
Lysogene Forms Solid Financial Team With Two Senior Appointments
1,157,778 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

